Suchergebnisse - "Karampitsakos, Theodoros"

PubPharm (6)

1

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19 : an open label, randomized controlled trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Karampitsakos, T. | Papaioannou, O. | Tsiri, P. | +16

2

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19 : an open label, prospective study

enthalten in: Respiratory research | 2021

von Karampitsakos, T. | Malakounidou, E. | Papaioannou, O. | +13

3

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

enthalten in: Respiratory research | 2021

von Karampitsakos, T. | Malakounidou, E. | Papaioannou, O. | +13

4

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

enthalten in: Respiratory research | 2021

von Karampitsakos, T. | Torrisi, S. | Antoniou, K. | +28

CommentIn: Respir Res. 2021 Oct 21;22(1):270. - PMID 34674703

5

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

enthalten in: Respiratory research | 2021

von Karampitsakos, T. | Torrisi, S. | Antoniou, K. | +28

6

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

enthalten in: Respiratory research | 05 May 2021

von Karampitsakos, T. | Torrisi, S. | Antoniou, K. | +28

1
[1]